Despite assurances from President Donald Trump’s administration in January that the coronavirus outbreak in the country is under control, new COVID cases in the country continued to rise. In fact, the U.S. is now the leading country in terms of the number of confirmed infections after surpassing China and Italy last week.
The recent development did not escape Hillary Clinton who has been consistently critical of President Donald Trump’s handling of the coronavirus pandemic. On Friday, the former Secretary of State took to Twitter mocking her former campaign rival and linking his “America First” slogan to the current top spot the U.S. occupies in terms of COVID-19 cases, according to Newsweek.
“He did promise ‘America First,’” Clinton tweeted. She also shared a New York Times article that reported how the U.S. became the country hardest hit by the coronavirus pandemic on Thursday.
There are now more than 150 thousand people confirmed to be infected with the virus in the U.S. There are now more than 2,800 reported deaths due to the virus.
Trump used the “America First” slogan during his 2016 campaign against Clinton. “We assembled here today are issuing a new decree to be heard in every city, in every foreign capital, and in every hall of power,” Trump said in his January 2017 inaugural address. “From this day forward, a new vision will govern our land. From this moment on, it's going to be America First.”
Clinton also criticized Trump for contradicting medical experts. “A month ago, Trump said: ‘It’s going to disappear. One day, it’s like a miracle, it will disappear,’” she wrote on a different post. “Yesterday, he said: ‘I don’t believe you need 40,000 or 30,000 ventilators.’ What will it take to get @realdonaldtrump to listen to experts instead of his own hunches?”
The former Secretary of State also criticized Trump’s response to the pandemic. “The Trump administration was told in January that coronavirus was likely to become a pandemic,” she wrote in a tweet last week. “They refused to act for fear of spooking the markets, losing weeks of time to prepare that we won't get back.”


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
HHS Adds New Members to Vaccine Advisory Panel Amid Legal and Market Uncertainty
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Marco Rubio to Brief Congress After U.S.-Israeli Strikes on Iran
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Pentagon Leaders Monitor U.S. Iran Operation from Mar-a-Lago
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Trump Announces U.S. Strikes on Iran Navy as Conflict Escalates
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
EU Urges Maximum Restraint in Iran Conflict Amid Fears of Regional Escalation and Oil Supply Disruption
Middle East Conflict Escalates After Khamenei’s Death as U.S., Israel and Iran Exchange Strikes
Trump Says U.S. Attacks on Iran Will Continue, Warns of More American Casualties
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



